Literature DB >> 429575

Determination of antithrombin activity by an amidolytic and a clotting procedure.

A Frigola, S Angeloni, A R Cerqueti.   

Abstract

Plasma antithrombin activity was measured using an amidolytic method (substrate Chromozym TH) and a clotting method. The mean antithrombin values found in 76 hospital outpatients were 9.4 micronmol/min/ml with the amidolytic procedure and 100.1% of antithrombin activity with the clotting procedure. The two methods correlate fairly well (r = 0.85, P less than 0.01) and show satisfactory reproducibility. Coefficients of variation of 5.9% and 8.8% were obtained respectively with the amidolytic and the clotting procedures. In the presence of very high levels of fibrinogen degradation products, falsely elevated antithrombin activity levels were observed with the clotting procedure but the amidolytic method is essentially unaffected. It is concluded that both methods are suitable for determining antithrombin activity but a well-standardised amidolytic procedure has advantages.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429575      PMCID: PMC1145561          DOI: 10.1136/jcp.32.1.21

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Problems in the assay of thrombin using synthetic peptides as substrates.

Authors:  P J Gaffney; K Lord; M Brasher; T B Kirkwood
Journal:  Thromb Res       Date:  1977-04       Impact factor: 3.944

3.  Evidence for a heparin-induced conformational change on antithrombin III.

Authors:  G B Villaneuva; I Danishefsky
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

4.  Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH).

Authors:  U Abildgaard; M Lie; O R Odegård
Journal:  Thromb Res       Date:  1977-10       Impact factor: 3.944

5.  Antifactor Xa activity measured with amidolytic methods.

Authors:  O R Odegård; M Lie; U Abildgaard
Journal:  Haemostasis       Date:  1976

6.  Standardisation of a simple method for the determination of antithrombin activity.

Authors:  A Frigola
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

7.  Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiency.

Authors:  O R Odegård; U Abildgaard
Journal:  Scand J Haematol       Date:  1977-02

8.  The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.

Authors:  B Osterud; M Miller-Andersson; U Abildgaard; H Prydz
Journal:  Thromb Haemost       Date:  1976-04-30       Impact factor: 5.249

9.  Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.

Authors:  D Collen; J Schetz; F de Cock; E Holmer; M Verstraete
Journal:  Eur J Clin Invest       Date:  1977-02       Impact factor: 4.686

10.  Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.

Authors:  R Machovich; A Borsodi; G Blaskó; S A Orakzai
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

View more
  2 in total

1.  Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.

Authors:  Katherine L Meyer-Siegler; Jacob Cox; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  Cancer Lett       Date:  2009-09-16       Impact factor: 8.679

2.  Comparison of three methods for the estimation of plasma antithrombin.

Authors:  D S McLellan; J D Devlin; G H Heyse-Moore; A Aronstam
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.